Cargando…
The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease
Most brain insulin comes from the pancreas and is taken up by the brain by what appears to be a receptor-based carrier. Type 2 diabetes animal models associated with insulin resistance show reduced insulin brain uptake and content. Recent data point to changes in the insulin receptor cascade in obes...
Autores principales: | Messier, Claude, Teutenberg, Kevin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565470/ https://www.ncbi.nlm.nih.gov/pubmed/16444902 http://dx.doi.org/10.1155/NP.2005.311 |
Ejemplares similares
-
Redox Regulation of Insulin Degradation by Insulin-Degrading Enzyme
por: Cordes, Crystal M., et al.
Publicado: (2011) -
Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021) -
Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme
por: González-Casimiro, Carlos M., et al.
Publicado: (2021) -
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
por: Corraliza-Gomez, Miriam, et al.
Publicado: (2023) -
The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimer's disease
por: Hayrabedyan, Soren, et al.
Publicado: (2018)